Episode Details

Petco Health and Wellness Company, Inc. Q1 FY2026 earnings breakdown - conversational walkthrough with a price-aware verdict and Wall Street consensus comparison. THE CALL: HOLD (3/5 conviction, MODERATE) - CURRENT @ $2.88 - HOLD - BUY below $2.20 with $1.50 stop - AVOID above $4.50 TRIGGER: Two consecutive quarters of positive comp sales AND positive GAAP EPS, OR a material debt refinancing that reduces leverage below 3x adjusted EBITDA WINDOW: Through Q3 FY2026 earnings (December 2026) TRACKER: chargedalpha.com WALL STREET CONSENSUS - Ratings: 0 Strong Buy / 3 Buy / 8 Hold / 4 Sell / 1 Strong Sell - HOLD - Median 12-month price target: $3.25 (range $2 - $5) - Charged Alpha vs consensus: IN LINE THESIS Petco is the largest brick-and-mortar specialty pet retailer in the US with 1,500+ stores, approximately 300 vet hospitals, and a grooming business -- a differentiated services model that Chewy cannot easily replicate online. Bull lever: Services revenue grew 10% year over year in Q1 FY26, comp sales turned positive for the first time in five quarters at +0.7%, and Adjusted EBITDA of $97.3M beat estimates by 5.7% -- the Phase 3 turnaround under Joel Anderson is showing measurable early progress. Key risk: Total debt of $1.482 billion against a market cap of $840M creates an asymmetric risk profile -- any sustained revenue weakness or multiple compression could make refinancing difficult, and the $840M equity is effectively a deep option on the turnaround succeeding. QUALITY CHECK - Management quality grade: B- (CEO Joel Anderson took over in 2023, launching the Phase 3 transformation. Early results on services growth and comp inflection are positive. However, GAAP losses persist and prior leadership made significant capital allocation errors (IPO at $18, debt-funded expansion). Execution grade improving but track record is short.) - Earnings quality grade: B- (GAAP EPS of -$0.05 vs Adj EPS of +$0.01 shows meaningful add-backs. Adjusted EBITDA beat is clean. Working capital dynamics drove FCF negative in Q1 -- seasonal but bears monitoring. Debt of $1.48B is the balance sheet overhang.) CHAPTERS 0:00 Hook 0:13 S0b_Year 0:39 The Print 1:33 S1b_BeatDecomp 2:08 The Trend 2:54 The Segments 3:42 The FCF Bridge 4:16 S4b_MarginQual 4:42 Guidance & The Narrative Diff 5:22 S5b_Catalyst 5:56 Peer Dot-Plot 6:23 S6b_Valuation 6:53 Management & Earnings Quality 7:47 S8a_Call 8:33 S8b_Call 9:28 Disclosure KEY METRICS - Q1 FY2026 - Revenue: $1.50B (YoY +0.2%, beat est by +0.3%) - EPS: $-0.05 (vs $0.01 est, beat -600.0%) - Operating margin: 1.6% - Free cash flow: $-0.07B (-4.6% margin) NARRATIVE DIFF - what changed in management tone - Prior call: "On the Q4 FY25 call, CEO Joel Anderson said Petco was transitioning to Phase 3 of its transformation -- Reach for the Sky -- focused on accelerating the services business, stabilizing the product base, and returning to positive comp sales growth." - This call: "We are pleased to return to positive comparable sales growth in Q1 and reaffirm our full-year outlook. Our services business continues to outperform and is a key engine of our long-term growth." - Tone shift: Revenue beat but GAAP EPS missed significantly. The comp inflection narrative is real (+0.7%), but the pace is modest and GAAP profitability remains negative. Stock fell 10.8% as markets weigh GAAP miss against operational progress. DATA SOURCES - FMP (financialmodelingprep.com) - Petco Health and Wellness Company, Inc. Q1 FY2026 press release + earnings call DISCLAIMER This is for informational and educational purposes only. Not financial advice. Charged Alpha does not have a position in WOOF. Do your own research before any investment decision. #WOOF #PetcoHealthandWellnessCompany,Inc. #earnings #investing #stocks #ChargedAlpha